Lecap Asset Management Ltd. Has $2.75 Million Stock Position in The Clorox Company (NYSE:CLX)

Lecap Asset Management Ltd. lifted its position in The Clorox Company (NYSE:CLX - Free Report) by 540.4% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 18,643 shares of the company's stock after buying an additional 15,732 shares during the quarter. Lecap Asset Management Ltd.'s holdings in Clorox were worth $2,745,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. Venturi Wealth Management LLC grew its position in Clorox by 380.0% in the fourth quarter. Venturi Wealth Management LLC now owns 360 shares of the company's stock worth $58,000 after acquiring an additional 285 shares in the last quarter. Global Retirement Partners LLC grew its position in Clorox by 45.7% in the fourth quarter. Global Retirement Partners LLC now owns 1,463 shares of the company's stock worth $238,000 after acquiring an additional 459 shares in the last quarter. Ieq Capital LLC grew its position in Clorox by 9.2% in the fourth quarter. Ieq Capital LLC now owns 5,874 shares of the company's stock worth $954,000 after acquiring an additional 494 shares in the last quarter. MONECO Advisors LLC grew its position in Clorox by 22.6% in the fourth quarter. MONECO Advisors LLC now owns 1,955 shares of the company's stock worth $318,000 after acquiring an additional 361 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in Clorox in the fourth quarter worth approximately $285,000. Institutional investors own 78.53% of the company's stock.

Analysts Set New Price Targets

Several analysts have commented on CLX shares. Wells Fargo & Company decreased their target price on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. UBS Group decreased their price objective on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a report on Tuesday, May 6th. Jefferies Financial Group decreased their price objective on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a report on Thursday. Finally, Evercore ISI set a $140.00 price objective on shares of Clorox and gave the stock an "underperform" rating in a report on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $149.50.

Clorox Price Performance

Shares of CLX stock traded up $1.08 during mid-day trading on Friday, reaching $119.09. The company's stock had a trading volume of 5,265,025 shares, compared to its average volume of 1,385,979. The Clorox Company has a 1-year low of $117.35 and a 1-year high of $171.37. The company has a market cap of $14.68 billion, a P/E ratio of 21.38, a PEG ratio of 2.67 and a beta of 0.54. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The firm's 50-day moving average is $131.21 and its two-hundred day moving average is $145.27.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the prior year, the company posted $1.71 EPS. The company's quarterly revenue was down 8.0% compared to the same quarter last year. On average, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Insider Activity

In other news, Director Pierre R. Breber bought 4,000 shares of the company's stock in a transaction that occurred on Wednesday, May 7th. The stock was acquired at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the transaction, the director now directly owns 4,000 shares of the company's stock, valued at $546,280. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.57% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.